- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场最近连续上涨中，短期小心回调。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
- 波段诊断：
-
技术面诊股
诊断结果：1.0技术面打败了0%的股票
技术面评分前10的股票
近期的平均成本为16.10元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为16.10元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.10","date":1736934648,"color":"0x9f0ba1"}]
市场表现
该股为新上市股票，上市以来表现良好，呈上升趋势。
[{"date":"2025.01.16","stock":"-3.36","trade":"0.35","ind":"0.28"},{"date":"2025.01.15","stock":"-13.08","trade":"-1.08","ind":"-0.43"},{"date":"2025.01.14","stock":"8.04","trade":"3.51","ind":"2.54"},{"date":"2025.01.13","stock":"-15.89","trade":"-0.10","ind":"-0.24"},{"date":"2025.01.10","stock":"379.17","trade":"-3.04","ind":"-1.33"},{"date":"2025.01.09","stock":false,"trade":"-0.98","ind":"-0.58"},{"date":"2025.01.08","stock":false,"trade":"-0.11","ind":"0.02"},{"date":"2025.01.07","stock":false,"trade":"-1.45","ind":"0.71"},{"date":"2025.01.06","stock":false,"trade":"2.74","ind":"-0.14"},{"date":"2025.01.03","stock":false,"trade":"-0.75","ind":"-1.57"},{"date":"2025.01.02","stock":false,"trade":"-1.71","ind":"-2.66"},{"date":"2024.12.31","stock":false,"trade":"-1.84","ind":"-1.63"},{"date":"2024.12.30","stock":false,"trade":"-1.00","ind":"0.21"},{"date":"2024.12.27","stock":false,"trade":"1.07","ind":"0.06"},{"date":"2024.12.26","stock":false,"trade":"-0.12","ind":"0.14"},{"date":"2024.12.25","stock":false,"trade":"-1.85","ind":"-0.01"},{"date":"2024.12.24","stock":false,"trade":"0.66","ind":"1.26"},{"date":"2024.12.23","stock":false,"trade":"-3.17","ind":"-0.50"},{"date":"2024.12.20","stock":false,"trade":"0.88","ind":"-0.06"},{"date":"2024.12.19","stock":false,"trade":"-0.16","ind":"-0.36"},{"date":"2024.12.18","stock":false,"trade":"-0.40","ind":"0.62"}]
赛分科技,上证指数,化学制药指数
压力支撑
该股压力位为16.02元，支撑位为15.55元。
[{"text":"\u538b\u529b\u4f4d","value":"16.02","date":1736956800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.55","date":1736956800,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了83%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月16日 20:40
| 机构今日流向(万元) | -1017.73 | 机构5日流向(万元) | -3087.08 |
| 机构10日流向(万元) | -7610.77 | 机构20日流向(万元) | -16219.04 |
消息面诊股
诊断结果：5消息面打败了92%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- C赛分：1月15日获融资买入1826.79万元
2025-01-16 - 南大校友，拿下2025年科创板“头彩”
2025-01-15 - C赛分：1月14日获融资买入2531.79万元，占
2025-01-15 - 苏州诞生2025年第一家上市公司
2025-01-14 - C赛分：1月13日获融资买入2256.89万元
2025-01-14 - 南大校友创业，这家生物医药上游企业IPO
2025-01-13 - 开门红！江苏2025年首家上市公司来了
2025-01-10 - 赛分科技上市募2.2亿首日涨379% 业绩成长性曾
2025-01-10 - 来自苏州工业园区！2025年科创板首只新股赛分科技
2025-01-10 - 科创板新股N赛分尾盘涨幅收窄至356% 较开盘价跌
2025-01-10
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.8行业面打败了26%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.01.16","price":"0.28","value":"0.35"},{"date":"2025.01.15","price":"-0.43","value":"-1.08"},{"date":"2025.01.14","price":"2.54","value":"3.51"},{"date":"2025.01.13","price":"-0.24","value":"-0.10"},{"date":"2025.01.10","price":"-1.33","value":"-3.04"},{"date":"2025.01.09","price":"-0.58","value":"-0.98"},{"date":"2025.01.08","price":"0.02","value":"-0.11"},{"date":"2025.01.07","price":"0.71","value":"-1.45"},{"date":"2025.01.06","price":"-0.14","value":"2.74"},{"date":"2025.01.03","price":"-1.57","value":"-0.75"},{"date":"2025.01.02","price":"-2.66","value":"-1.71"},{"date":"2024.12.31","price":"-1.63","value":"-1.84"},{"date":"2024.12.30","price":"0.21","value":"-1.00"},{"date":"2024.12.27","price":"0.06","value":"1.07"},{"date":"2024.12.26","price":"0.14","value":"-0.12"},{"date":"2024.12.25","price":"-0.01","value":"-1.85"},{"date":"2024.12.24","price":"1.26","value":"0.66"},{"date":"2024.12.23","price":"-0.50","value":"-3.17"},{"date":"2024.12.20","price":"-0.06","value":"0.88"},{"date":"2024.12.19","price":"-0.36","value":"-0.16"},{"date":"2024.12.18","price":"0.62","value":"-0.40"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 信立泰 | 3191.11% | -1.66% | 5.4分 |
| 2 | 海翔药业 | 193.90% | -0.82% | 4.8分 |
| 3 | 富祥药业 | 162.75% | 5.10% | 3.9分 |
| 4 | 奥锐特 | 72.42% | 0.82% | 5.6分 |
| 5 | 鲁抗医药 | 12.22% | -9.31% | 4.8分 |
| 6 | 广生堂 | 10.88% | -2.57% | 4.6分 |
| 8 | *ST景峰 | 7.71% | 0.21% | 5.2分 |
| 10 | 艾力斯 | 4.30% | 11.84% | 6.6分 |
| 12 | 华纳药厂 | 2.74% | 4.79% | 6.2分 |
| 14 | 泰恩康 | 2.43% | 5.33% | 5.0分 |
| 16 | 立方制药 | 0.16% | 4.03% | 6.2分 |
| 18 | 常山药业 | 0.00% | 13.31% | 4.5分 |
| 20 | 力生制药 | -0.18% | -4.74% | 3.6分 |
| 22 | 天新药业 | -1.26% | 3.61% | 5.7分 |
| 24 | 金石亚药 | -1.36% | -11.16% | 4.3分 |
| 26 | 贝达药业 | -2.15% | 2.60% | 5.2分 |
| 28 | 东诚药业 | -2.46% | 1.24% | 5.2分 |
| 30 | 人福医药 | -2.86% | 10.52% | 5.7分 |
| 32 | 哈药股份 | -3.02% | -12.50% | 5.3分 |
| 34 | 新诺威 | -3.44% | 16.00% | 5.7分 |
| 36 | 浙江医药 | -3.76% | 0.72% | 5.1分 |
| 38 | 华润双鹤 | -3.89% | 0.73% | 6.1分 |
| 40 | 向日葵 | -4.25% | 7.64% | 5.0分 |
| 42 | 百利天恒 | -4.61% | 0.62% | 6.1分 |
| 44 | 健康元 | -4.94% | -1.46% | 5.3分 |
| 46 | ST三圣 | -5.09% | -1.44% | 4.4分 |
| 48 | 西点药业 | -5.17% | -4.80% | 4.7分 |
| 50 | 永安药业 | -5.46% | 1.27% | 4.8分 |
| 52 | 博瑞医药 | -5.97% | 2.70% | 5.7分 |
| 54 | 辰欣药业 | -5.98% | 1.07% | 4.9分 |
| 56 | 川宁生物 | -6.41% | 1.92% | 4.9分 |
| 58 | 迪哲医药 | -6.87% | 4.07% | 5.5分 |
| 60 | 本立科技 | -7.40% | 1.54% | 4.9分 |
| 62 | 美诺华 | -7.59% | -0.32% | 4.7分 |
| 64 | 华邦健康 | -7.87% | 0.46% | 4.4分 |
| 66 | 同和药业 | -7.93% | -1.29% | 4.1分 |
| 68 | 吉贝尔 | -8.15% | -0.50% | 4.8分 |
| 70 | 天宇股份 | -8.43% | -1.06% | 4.1分 |
| 72 | 海辰药业 | -8.49% | -6.49% | 4.4分 |
| 74 | 千红制药 | -8.85% | -1.87% | 4.4分 |
| 76 | 神奇制药 | -8.99% | -4.85% | 4.6分 |
| 78 | 仟源医药 | -9.21% | -0.60% | 4.1分 |
| 80 | 纳微科技 | -9.32% | 0.90% | 4.8分 |
| 82 | 赛隆药业 | -9.46% | 3.79% | 5.1分 |
| 84 | 宏源药业 | -9.70% | 0.77% | 4.1分 |
| 86 | 亿帆医药 | -9.72% | -1.73% | 4.5分 |
| 88 | 复旦张江 | -9.93% | 0.96% | 4.5分 |
| 90 | 海欣股份 | -10.30% | 11.17% | 5.9分 |
| 92 | 卫信康 | -10.34% | -0.93% | 4.9分 |
| 94 | 福安药业 | -10.40% | -1.15% | 4.1分 |
| 96 | 易明医药 | -10.70% | 9.74% | 5.4分 |
| 98 | 海普瑞 | -11.21% | -0.20% | 4.4分 |
| 100 | 莎普爱思 | -11.45% | 0.61% | 5.2分 |
| 102 | 罗欣药业 | -11.53% | -6.93% | 4.1分 |
| 104 | 中关村 | -12.14% | 0.44% | 4.6分 |
| 106 | 舒泰神 | -12.28% | -3.52% | 4.3分 |
| 108 | 拓新药业 | -12.52% | -4.06% | 3.3分 |
| 110 | 共同药业 | -12.57% | -0.26% | 3.8分 |
| 112 | 司太立 | -13.44% | -0.61% | 4.2分 |
| 114 | 康芝药业 | -13.87% | 1.06% | 4.1分 |
| 116 | 盟科药业 | -13.95% | -1.03% | 4.6分 |
| 118 | 北陆药业 | -14.08% | 0.66% | 4.4分 |
| 120 | 翰宇药业 | -14.24% | -5.12% | 4.2分 |
| 122 | 海南海药 | -15.06% | 0.88% | 4.1分 |
| 124 | 华海药业 | -16.56% | -4.54% | 4.7分 |
| 126 | 尔康制药 | -17.59% | 0.00% | 3.9分 |
| 128 | 复旦复华 | -19.68% | 4.68% | 5.0分 |
| 130 | 一品红 | -20.14% | -4.38% | 3.8分 |
| 132 | 悦康药业 | -22.55% | 0.69% | 5.7分 |
| 134 | ST天圣 | -24.17% | -10.34% | 4.1分 |
| 136 | 莱美药业 | -33.46% | 2.58% | 3.8分 |
| 138 | *ST普利 | -58.77% | -15.66% | 2.8分 |
| 140 | 恒瑞医药 | -5530.38% | -3.14% | 5.3分 |
| 142 | 上海谊众 | - | 0.23% | 5.3分 |
| 144 | 亨迪药业 | - | -17.67% | 2.8分 |
| 146 | 华仁药业 | - | 0.00% | 3.9分 |
| 148 | 双鹭药业 | - | -1.60% | 3.3分 |
| 150 | 广济药业 | - | -8.61% | 4.6分 |
| 152 | 新华制药 | - | -0.33% | 3.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 67/229 ， 23/229。
[{"date":"2024-09-30","value":"5.31","vol":"4.52"},{"date":"2024-06-30","value":"3.74","vol":"3.49"},{"date":"2023-12-31","value":"5.42","vol":"-2.41"},{"date":"2023-09-30","value":"3.48","vol":"2.53"},{"date":"2023-06-30","value":"3.24","vol":"2.39"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.31 | 3.74 | 5.42 | 3.48 | 3.24 |
| 行业(%) | 4.52 | 3.49 | -2.41 | 2.53 | 2.39 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"73.83","vol":"50.55"},{"date":"2024-06-30","value":"74.44","vol":"50.91"},{"date":"2023-12-31","value":"71.21","vol":"51.63"},{"date":"2023-09-30","value":"69.33","vol":"51.68"},{"date":"2023-06-30","value":"68.02","vol":"51.41"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
73.83 | 74.44 | 71.21 | 69.33 | 68.02 |
| 行业(%) | 50.55 | 50.91 | 51.63 | 51.68 | 51.41 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/229 ， 32/229。
[{"date":"2024-09-30","value":"25.70","vol":"44.93"},{"date":"2024-06-30","value":"13.55","vol":"700.68"},{"date":"2023-12-31","value":"15.24","vol":"353.65"},{"date":"2023-09-30","value":"42.50","vol":"122.98"},{"date":"2023-06-30","value":"79.21","vol":"16.76"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
25.70 | 13.55 | 15.24 | 42.50 | 79.21 |
| 行业(%) | 44.93 | 700.68 | 353.65 | 122.98 | 16.76 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"63.04","vol":"-16.98"},{"date":"2024-06-30","value":"22.59","vol":"7.37"},{"date":"2023-12-31","value":"11.34","vol":"-47.20"},{"date":"2023-09-30","value":"","vol":"13.96"},{"date":"2023-06-30","value":"230.91","vol":"9.90"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
63.04 | 22.59 | 11.34 | - | 230.91 |
| 行业(%) | -16.98 | 7.37 | -47.20 | 13.96 | 9.90 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 115/229 ， 138/229。
[{"date":"2024-09-30","value":"0.19","vol":"0.33"},{"date":"2024-06-30","value":"0.14","vol":"0.23"},{"date":"2023-12-31","value":"0.23","vol":"0.44"},{"date":"2023-09-30","value":"0.16","vol":"0.33"},{"date":"2023-06-30","value":"0.13","vol":"0.23"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.19 | 0.14 | 0.23 | 0.16 | 0.13 |
| 行业(次) | 0.33 | 0.23 | 0.44 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.56","vol":"2.16"},{"date":"2024-06-30","value":"0.38","vol":"1.50"},{"date":"2023-12-31","value":"0.72","vol":"2.78"},{"date":"2023-09-30","value":"","vol":"2.03"},{"date":"2023-06-30","value":"0.45","vol":"1.38"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.56 | 0.38 | 0.72 | - | 0.45 |
| 行业(次) | 2.16 | 1.50 | 2.78 | 2.03 | 1.38 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/229 ， 150/229。
[{"date":"2024-09-30","value":"42.60","vol":"-10.05"},{"date":"2023-12-31","value":"1.10","vol":"-123.06"},{"date":"2023-09-30","value":"71.37","vol":"-16.07"},{"date":"2022-12-31","value":"26.47","vol":"26.47"}]
| 2024-09-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 | |
|---|---|---|---|---|
| 现金流量净额/营业收入 | 42.60 | 1.10 | 71.37 | 26.47 |
| 行业 | -10.05 | -123.06 | -16.07 | 26.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.57","vol":"0.00"},{"date":"2024-06-30","value":"0.65","vol":"2.18"},{"date":"2023-12-31","value":"0.76","vol":"2.34"},{"date":"2023-09-30","value":"0.73","vol":"0.00"},{"date":"2023-06-30","value":"0.98","vol":"2.49"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.57 | 0.65 | 0.76 | 0.73 | 0.98 |
| 行业 | 0.00 | 2.18 | 2.34 | 0.00 | 2.49 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 146/229 ， 140/229。
[{"date":"2024-09-30","value":"13.78","vol":"3.65"},{"date":"2024-06-30","value":"13.56","vol":"3.58"},{"date":"2023-12-31","value":"11.79","vol":"3.71"},{"date":"2023-09-30","value":"17.84","vol":"4.07"},{"date":"2023-06-30","value":"19.50","vol":"4.08"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
13.78 | 13.56 | 11.79 | 17.84 | 19.50 |
| 行业 | 3.65 | 3.58 | 3.71 | 4.07 | 4.08 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"8.36","vol":"2.91"},{"date":"2024-06-30","value":"8.09","vol":"2.88"},{"date":"2023-12-31","value":"8.82","vol":"3.01"},{"date":"2023-09-30","value":"17.84","vol":"3.33"},{"date":"2023-06-30","value":"15.24","vol":"3.37"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
8.36 | 8.09 | 8.82 | 17.84 | 15.24 |
| 行业 | 2.91 | 2.88 | 3.01 | 3.33 | 3.37 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 143/229 ， 143/229。
[{"date":"2024-09-30","value":"6.91","vol":"33.03"},{"date":"2024-06-30","value":"7.19","vol":"33.21"},{"date":"2023-12-31","value":"8.73","vol":"33.46"},{"date":"2023-09-30","value":"8.30","vol":"32.26"},{"date":"2023-06-30","value":"8.35","vol":"32.81"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
6.91 | 7.19 | 8.73 | 8.30 | 8.35 |
| 行业(%) | 33.03 | 33.21 | 33.46 | 32.26 | 32.81 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.07","vol":"0.73"},{"date":"2024-06-30","value":"0.08","vol":"0.71"},{"date":"2023-12-31","value":"0.10","vol":"0.75"},{"date":"2023-09-30","value":"0.09","vol":"0.71"},{"date":"2023-06-30","value":"0.09","vol":"0.71"}]
| 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.07 | 0.08 | 0.10 | 0.09 | 0.09 |
| 行业(%) | 0.73 | 0.71 | 0.75 | 0.71 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.52","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]